Foghorn Therapeutics, Inc. (FHTX)
6.075
-0.14
(-2.33%)
USD |
NASDAQ |
Aug 28, 14:19
Foghorn Therapeutics 1 Year Total Returns (Daily) : 14.97% for Aug. 27, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 27, 2026 | 14.97% |
| August 26, 2026 | 20.98% |
| August 25, 2026 | 30.48% |
| August 24, 2026 | 23.56% |
| August 21, 2026 | 40.28% |
| August 20, 2026 | 33.27% |
| August 19, 2026 | 46.17% |
| August 18, 2026 | 32.35% |
| August 17, 2026 | 35.34% |
| August 14, 2026 | 21.67% |
| August 13, 2026 | 25.53% |
| August 12, 2026 | 36.34% |
| August 11, 2026 | 39.92% |
| August 10, 2026 | 36.24% |
| August 07, 2026 | 21.89% |
| August 06, 2026 | 13.67% |
| August 05, 2026 | -2.40% |
| August 04, 2026 | -5.45% |
| August 03, 2026 | -7.62% |
| July 31, 2026 | -13.71% |
| July 30, 2026 | -13.03% |
| July 29, 2026 | -19.73% |
| July 28, 2026 | -21.08% |
| July 27, 2026 | -15.99% |
| July 24, 2026 | -21.65% |
| Date | Value |
|---|---|
| July 23, 2026 | -21.64% |
| July 22, 2026 | -17.82% |
| July 21, 2026 | -15.41% |
| July 20, 2026 | -15.33% |
| July 17, 2026 | -14.92% |
| July 16, 2026 | -13.78% |
| July 15, 2026 | -6.03% |
| July 14, 2026 | -8.50% |
| July 13, 2026 | 0.74% |
| July 10, 2026 | 10.19% |
| July 09, 2026 | 9.07% |
| July 08, 2026 | 26.18% |
| July 07, 2026 | 25.52% |
| July 06, 2026 | -1.56% |
| July 02, 2026 | 7.07% |
| July 01, 2026 | 2.87% |
| June 30, 2026 | 3.83% |
| June 29, 2026 | 0.41% |
| June 26, 2026 | -13.17% |
| June 25, 2026 | -17.76% |
| June 24, 2026 | -16.22% |
| June 23, 2026 | -15.34% |
| June 22, 2026 | -11.44% |
| June 18, 2026 | -12.63% |
| June 17, 2026 | -15.45% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Prime Medicine, Inc. | 6.12% |
| Arrowhead Pharmaceuticals, Inc. | 306.6% |
| Oncolytics Biotech, Inc. | -19.81% |
| Sangamo Therapeutics, Inc. | -71.51% |
| Sarepta Therapeutics, Inc. | 19.48% |